TELEHEART Trial: Telemedicine-guided Uptitration of Therapy in Chronic Heart Failure
Sponsor: Azienda Unita Sanitaria Locale di Piacenza
Trial Details
| Condition | Heart Failure With Reduced Ejection Fraction (HFrEF) |
| Intervention | Telemedicine-based follow-up; Standard follow-up |
| Phase | NA |
| Status | Recruiting |
| Participants | 90 |
| Est. Completion | 1 Mar 2028 |
| Last Updated | 18 May 2026 |
Primary Outcome
Change in guideline-directed medical therapy (GDMT) score
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age ≥18 years * New diagnosis of heart failure with reduced ejection fraction (HFrEF) * Recent hospitalization for heart failure with planned post-discharge follow-up * Eligible for optimization of guideline-directed medical therapy (GDMT) according to current guidelines * Ability to provide informed consent * Availability of caregiver support if required for telemedicine use * Access to a smartphone or compatible device for telemedicine and remote monitoring Exclusion Criteria: * Ongoing treatment with two or more guideline-directed heart failure medications at the time of HFrEF diagnosis * Presence of severe comorbidities or clinical instability requiring prolonged or continuous hospital management * Estimated life expectancy \<12 months * Pregnancy or breastfeeding
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service